Literature DB >> 5387567

Vibriocidal antibody in clinical cholera.

W M McCormack, J Chakraborty, A S Rahman, W H Mosley.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5387567     DOI: 10.1093/infdis/120.2.192

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

Review 2.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

3.  Furazolidone in paediatric cholera.

Authors:  A W Karchmer; G T Curlin; M I Huq; N Hirschhorn
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Experimental Cholera in Chinchillas: the Immune Response in Serum and Intestinal Secretions to Vibrio cholerae and Cholera Toxin.

Authors:  U Blachman; S R Graboff; G E Haag; E Gottfeld; M J Pickett
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

5.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.